Istari Oncology

Istari Oncology

生物技术研究

Durham,North Carolina 3,241 位关注者

Innovative Immunotherapy for cancer treatment

关于我们

Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The company was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center in 2016. Both are leaders in their respective research fields of virology, immunology, monoclonal development and clinical medicine, particularly in the treatment of brain tumors.

网站
https://istarioncology.com
所属行业
生物技术研究
规模
2-10 人
总部
Durham,North Carolina
类型
私人持股
创立
2016

地点

Istari Oncology员工

相似主页

查看职位

融资

Istari Oncology 共 3 轮

上一轮

未知

US$43,400,000.00

Crunchbase 上查看更多信息